Lakefront Biotherapeutics NV Earnings
The next earnings date for Lakefront Biotherapeutics NV is August 10, 2026.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Lakefront Biotherapeutics NV Earnings
| 08/10/2026 | $-11.50 |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Lakefront Biotherapeutics NV Earnings: Historical
| 05/07/2026 | --- | $0.21 | 121.65% |
| 03/26/2026 | After Market | $12.27 | 17,628.57% |
| 11/05/2025 | After Market | $-0.18 | 35.71% |
| 07/23/2025 | After Market | $-0.93 | -615.38% |
| 04/23/2025 | After Market | $0.97 | 638.89% |
| 02/13/2025 | --- | $0.41 | --- |
| 10/30/2024 | After Market | $-0.74 | -516.67% |
| 08/01/2024 | After Market | $0.07 | 450.00% |
| 05/02/2024 | After Market | $0.36 | 376.92% |
| 11/02/2023 | After Market | $0.39 | 145.88% |
More About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
“Lakefront Biotherapeutics NV Earnings” Can Refer to the Lakefront Biotherapeutics NV Earnings Date
Some people say “Lakefront Biotherapeutics NV earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Lakefront Biotherapeutics NV position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Lakefront Biotherapeutics NV Stock on the Earnings Date
If you own Lakefront Biotherapeutics NV stock (LKFT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Lakefront Biotherapeutics NV might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Lakefront Biotherapeutics NV shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Lakefront Biotherapeutics NV Earnings
You can contact us any time if you would like to ask questions about Lakefront Biotherapeutics NV earnings or anything else related to the stock market.